Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Code Corporation is a medical technology and data-capture company that develops barcode scanning hardware, scan engines, and software used heavily in healthcare workflows. The company is best known for image-based barcode readers and mobile/software decoding products that support patient identification, medication administration, specimen tracking, pharmacy, laboratory, and broader track-and-trace applications. Although not a drug-development biotech or pharma company, it is clearly healthcare-related because a substantial portion of its business serves hospitals and clinical care settings. Code was acquired by Brady Corporation in June 2021 for approximately $173 million and continues to operate as the Code brand within Brady. Its offerings are commercial-stage products rather than therapeutic pipeline assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Code Corporation.